Dr David W Beezhold, DO - Medicare Infectious Disease in Burr Ridge, IL

Dr David W Beezhold, DO is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Burr Ridge, Illinois. He went to Midwestern University, Chicago College Of Osteopathic Med and graduated in 1991 and has 33 years of diverse experience with area of expertise as Infectious Disease. He is a member of the group practice Metro Infectious Disease Consultants Llc and his current practice location is 901 Mcclintock Dr, Suite 201, Burr Ridge, Illinois. You can reach out to his office (for appointments etc.) via phone at (888) 220-6432.

Dr David W Beezhold is licensed to practice in Illinois (license number 036-086936) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1306832860.

Contact Information

Dr David W Beezhold, DO
901 Mcclintock Dr, Suite 201,
Burr Ridge, IL 60527-0872
(888) 220-6432
(630) 654-4253



Physician's Profile

Full NameDr David W Beezhold
GenderMale
SpecialityInfectious Disease
Experience33 Years
Location901 Mcclintock Dr, Burr Ridge, Illinois
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr David W Beezhold attended and graduated from Midwestern University, Chicago College Of Osteopathic Med in 1991
  NPI Data:
  • NPI Number: 1306832860
  • Provider Enumeration Date: 09/21/2005
  • Last Update Date: 12/21/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 4981516572
  • Enrollment ID: I20100130000079

Medical Identifiers

Medical identifiers for Dr David W Beezhold such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1306832860NPI-NPPES
036-086-936MedicaidIL
200856800MedicaidIN
0420273MedicaidIA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RI0200XInternal Medicine - Infectious Disease 3418 (Iowa)Secondary
207RI0200XInternal Medicine - Infectious Disease 02002583A (Indiana)Secondary
207RI0200XInternal Medicine - Infectious Disease 036-086936 (Illinois)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Palos Community HospitalPalos heights, ILHospital
Elmhurst Memorial HospitalElmhurst, ILHospital
Presence St Marys HospitalKankakee, ILHospital
Advocate Good Samaritan HospitalDowners grove, ILHospital
Adventist La Grange Memorial HospitalLa grange, ILHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Metro Infectious Disease Consultants Llc3072425784297

News Archive

Telly tubby toddlers at risk for poor health

Young children who watch too much television are at risk of becoming overweight and unfit as they approach puberty, show US researchers.

Study supports hypothesis that disulfiram reduces drug consumption by blocking DβH

​Disulfiram was the first medication approved for the treatment of alcoholism over 50 years ago. It works, at least in part, by preventing the metabolism of an alcohol by-product, acetaldehyde. High levels of acetaldehyde in the body quickly cause unpleasant symptoms, including nausea, vomiting, headache, and accelerated heart rate. Thus, disulfiram provides a very strong incentive to avoid drinking.

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.

NextDocs receives $10.3 million in Series A financing

NextDocs Corporation, the global leader in Microsoft SharePoint based software solutions for life sciences industries, today announced that the Company has received $10.3 million in a Series A financing from OpenView Venture Partners.

China's census shows aging population; Officials say family planning policies to be maintained

China's latest census shows that the proportion of elderly people in the country has increased, while the proportion of young people dropped significantly, but "leaders are refusing to relax strict family planning controls that are part of the cause," the Associated Press reports (4/28).

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr David W Beezhold allows following entities to bill medicare on his behalf.
Entity NameMetro Infectious Disease Consultants Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1235125717
PECOS PAC ID: 3072425784
Enrollment ID: O20031103000274

News Archive

Telly tubby toddlers at risk for poor health

Young children who watch too much television are at risk of becoming overweight and unfit as they approach puberty, show US researchers.

Study supports hypothesis that disulfiram reduces drug consumption by blocking DβH

​Disulfiram was the first medication approved for the treatment of alcoholism over 50 years ago. It works, at least in part, by preventing the metabolism of an alcohol by-product, acetaldehyde. High levels of acetaldehyde in the body quickly cause unpleasant symptoms, including nausea, vomiting, headache, and accelerated heart rate. Thus, disulfiram provides a very strong incentive to avoid drinking.

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.

NextDocs receives $10.3 million in Series A financing

NextDocs Corporation, the global leader in Microsoft SharePoint based software solutions for life sciences industries, today announced that the Company has received $10.3 million in a Series A financing from OpenView Venture Partners.

China's census shows aging population; Officials say family planning policies to be maintained

China's latest census shows that the proportion of elderly people in the country has increased, while the proportion of young people dropped significantly, but "leaders are refusing to relax strict family planning controls that are part of the cause," the Associated Press reports (4/28).

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David W Beezhold is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr David W Beezhold, DO
901 Mcclintock Dr, Suite 202,
Burr Ridge, IL 60527-0872

Ph: (888) 220-6432
Dr David W Beezhold, DO
901 Mcclintock Dr, Suite 201,
Burr Ridge, IL 60527-0872

Ph: (888) 220-6432

News Archive

Telly tubby toddlers at risk for poor health

Young children who watch too much television are at risk of becoming overweight and unfit as they approach puberty, show US researchers.

Study supports hypothesis that disulfiram reduces drug consumption by blocking DβH

​Disulfiram was the first medication approved for the treatment of alcoholism over 50 years ago. It works, at least in part, by preventing the metabolism of an alcohol by-product, acetaldehyde. High levels of acetaldehyde in the body quickly cause unpleasant symptoms, including nausea, vomiting, headache, and accelerated heart rate. Thus, disulfiram provides a very strong incentive to avoid drinking.

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.

NextDocs receives $10.3 million in Series A financing

NextDocs Corporation, the global leader in Microsoft SharePoint based software solutions for life sciences industries, today announced that the Company has received $10.3 million in a Series A financing from OpenView Venture Partners.

China's census shows aging population; Officials say family planning policies to be maintained

China's latest census shows that the proportion of elderly people in the country has increased, while the proportion of young people dropped significantly, but "leaders are refusing to relax strict family planning controls that are part of the cause," the Associated Press reports (4/28).

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Burr Ridge, IL

Chad T Whelan, MD
Infectious Disease
Medicare: Medicare Enrolled
Practice Location: 180 Harvester Dr Ste 110, Burr Ridge, IL 60527
Phone: 773-834-4064    
Dr. Vyjayanthi Atluri, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 6101 S County Line Rd, Burr Ridge, IL 60527
Phone: 630-686-9000    
Alan R Leff, MD
Infectious Disease
Medicare: Not Enrolled in Medicare
Practice Location: 180 Harvester Dr Ste 110, Burr Ridge, IL 60527
Phone: 773-834-4064    
Jayant Malhotra, M.D.
Infectious Disease
Medicare: Not Enrolled in Medicare
Practice Location: 25 Rodeo Dr, Burr Ridge, IL 60527
Phone: 630-789-6618    
Edgar Davila,
Infectious Disease
Medicare: Not Enrolled in Medicare
Practice Location: 124 79th St, Burr Ridge, IL 60527
Phone: 773-641-2037    
William Stoecker, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 901 Mcclintock Dr Ste 202, Burr Ridge, IL 60527
Phone: 888-220-6432    
Sarah H Glavin, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 180 Harvester Dr Ste 110, Burr Ridge, IL 60527
Phone: 773-834-4064    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.